Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,469 | -11,457 | -4,786 | -20,606 | -15,774 |
| Depreciation Amortization | 6 | 4 | 2 | 23 | 21 |
| Accounts payable and accrued liabilities | -64 | 335 | -121 | 128 | -921 |
| Other Working Capital | -2,020 | -2,952 | -1,900 | -1,156 | -702 |
| Other Operating Activity | 5,310 | 3,243 | 1,927 | 5,139 | 4,569 |
| Operating Cash Flow | $-16,237 | $-10,827 | $-4,878 | $-16,472 | $-12,807 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19 | -13 | -13 | -9 | -9 |
| Purchase Of Investment | -2,700 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-2,719 | $-13 | $-13 | $-9 | $-9 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 113,877 | 113,877 |
| Other Financing Activity | 0 | 0 | 0 | -573 | -574 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $113,304 | $113,303 |
| Exchange Rate Effect | -54 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 136,487 | 136,487 | 136,487 | 39,664 | 39,664 |
| End Cash Position | 117,477 | 125,647 | 131,596 | 136,487 | 140,151 |
| Net Cash Flow | $-19,010 | $-10,840 | $-4,891 | $96,823 | $100,487 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,237 | -10,827 | -4,878 | -16,472 | -12,807 |
| Capital Expenditure | -19 | -13 | -13 | -9 | -9 |
| Free Cash Flow | -16,256 | -10,840 | -4,891 | -16,481 | -12,816 |